The IRISCAT Alliance is a cooperative work space formed by the 7 research and innovation institutes linked to the ICS, in a first phase; the mechanisms for future incorporation of other centers will be established. The objective of the alliance is to take advantage of the synergies of the institutes to enhance and make the translational and clinical research of the Catalan health system more competitive, in order to enhance this reference hub in southern Europe.
At the IGTP TODAY
Researchers at the IGTP and Germans Trias Hospital have published new research in Frontiers in Immunology on the behaviour of dendritic cells (DC) during the development of type 1 diabetes (T1D) in children. These cells are involved in both the destruction of beta cells in T1D and the regulation of the immune response. This paper fills an important gap in knowledge about the disease in children.
The VIII edition of the Pedrera Talents prizes were presented last Thursday at the Pedrera. Three institutions participate in the awards, promoted by the Catalunya la Pedrera Foundation: they are the Germans Trias i Pujol Research Institute (IGTP), the Clinic Hospital Barcelona and the Vall d'Hebron Institute of Oncology.
The IGTP promotes science for high-school students at the celebration of the 24th Science Week at Can Ruti
This week the IGTP and other centres hosted the “Can Ruti Open Door Session” within Science Week in Badalona; the Science Week is a national event organized by the Spanish Foundation for Science and Technology (FECYT). This year nearly 200 high school students from various educational centres have visited the research facilities at nine different organizations on the Can Ruti Campus and learned about studies taking place there.
Yesterday evening the ceremony to present awards to the 43 projects that will receive funding for cancer research from the 2018 edition of the La Marató de TV3 and Catalunya Radio was held at the Academy of Medical Sciences. Three of the projects will be carried out under the leadership of Germans Trias professionals.
Badalona receives the maximum award from the European Commission as a place of innovation in active and healthy aging
The IGTP is one of the participating institutions working to promote this along with other research institutions and also others from academia, business and the third sector. Badalona Health Services (Badalona Serveis Assistencials, BSA), the municipal health organization promoted the candidature. BSA is part of an ecosystem of over 30 bodies and associations who make the local area eligible for the award.
The Centre for Comparative Medicine and Bioimage (CMCiB) now forms part of the Working Group on European 3Rs Centres. This literally puts it on the map, for European 3Rs Research and it has been included in the Norwegian NORECOPA website, which is currently the largest resource on European 3rs Research available. The Working Group is preparing the setting up of a European 3Rs Center Network to promote and facilitate ethical research.
On 22 August the IGTP received the HR Excellence in Research Award (HRS4R) from the European Commission (EC). The Commission's human resource strategy is aimed at aligning HR policies across European research institutions with the goal of making the movement of researchers between institutions easier and conditions fairer. The IGTP can use the HRS4R logo to identify itself as one of the 490 organizations now recognized as working towards this goal.
Two students have been awarded INPhINIT grants by “la Caixa” Foundation to complete their PhDs on the Can Ruti Campus. Emma Koehorst, has been working on Myotonic Dystrophy in the Neuromuscular and Neuropaediatric research group led by Gisela Nogales at the IGTP since last September. Ifeanyi Ezeonwumelu has started working at the IrsiCaixa on novel therapeutic strategies for HIV with Dr Ester Ballana Guix in the HIV Pathogenesis Group, led by Dr José A Esté.
This July the Government of Catalonia officially approved the Plan for Prevention and Control of Hepatitis in Catalonia, which aims to facilitate the adoption and implementation of measures to reduce the number of cases and the morbidity and mortality associated with this infection. This is in line with the goal of the WHO, which aims to eliminate hepatitis C by 2030. The plan is the result of healthcare and public health professionals, experts, representatives of scientific societies and organizations and patients and families associations all working together.